---
document_datetime: 2023-09-21 20:02:48
document_pages: 2
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/lamivudine-teva-pharma-bv-epar-all-authorised-presentations_en.pdf
document_name: lamivudine-teva-pharma-bv-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 2.0439886
conversion_datetime: 2025-12-27 15:47:34.994892
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
| MA (EU) number   | (Invented) name             | Strength   | Pharmaceutical form   | Route of administration   | Immediate Packaging                   | Pack size   |
|------------------|-----------------------------|------------|-----------------------|---------------------------|---------------------------------------|-------------|
| EU/1/09/596/001  | Lamivudine Teva Pharma B.V. | 150 mg     | Film-coated tablet    | Oral use                  | Blister (PVC/PVdC/alu)                | 20 tablets  |
| EU/1/09/596/002  | Lamivudine Teva Pharma B.V. | 150 mg     | Film-coated tablet    | Oral use                  | Blister (PVC/PVdC/alu)                | 30 tablets  |
| EU/1/09/596/003  | Lamivudine Teva Pharma B.V. | 150 mg     | Film-coated tablet    | Oral use                  | Blister (PVC/PVdC/alu)                | 60 tablets  |
| EU/1/09/596/004  | Lamivudine Teva Pharma B.V. | 150 mg     | Film-coated tablet    | Oral use                  | Blister (PVC/PVdC/alu)                | 90 tablets  |
| EU/1/09/596/005  | Lamivudine Teva Pharma B.V. | 150 mg     | Film-coated tablet    | Oral use                  | Blister (PVC/PVdC/alu)                | 100 tablets |
| EU/1/09/596/006  | Lamivudine Teva Pharma B.V. | 150 mg     | Film-coated tablet    | Oral use                  | Blister (PVC/PVdC/alu)                | 500 tablets |
| EU/1/09/596/007  | Lamivudine Teva Pharma B.V. | 150 mg     | Film-coated tablet    | Oral use                  | Bottle (HDPE)                         | 60 tablets  |
| EU/1/09/596/008  | Lamivudine Teva Pharma B.V. | 300 mg     | Film-coated tablet    | Oral use                  | Blister (PVC/PVdC/alu)                | 20 tablets  |
| EU/1/09/596/009  | Lamivudine Teva Pharma B.V. | 300 mg     | Film-coated tablet    | Oral use                  | Blister (PVC/PVdC/alu)                | 30 tablets  |
| EU/1/09/596/010  | Lamivudine Teva Pharma B.V. | 300 mg     | Film-coated tablet    | Oral use                  | Blister (PVC/PVdC/alu)                | 60 tablets  |
| EU/1/09/596/011  | Lamivudine Teva Pharma B.V. | 300 mg     | Film-coated tablet    | Oral use                  | Blister (PVC/PVdC/alu)                | 90 tablets  |
| EU/1/09/596/012  | Lamivudine Teva Pharma B.V. | 300 mg     | Film-coated tablet    | Oral use                  | Blister (PVC/PVdC/alu)                | 100 tablets |
| EU/1/09/596/013  | Lamivudine Teva Pharma B.V. | 300 mg     | Film-coated tablet    | Oral use                  | Blister (PVC/PVdC/alu)                | 500 tablets |
| EU/1/09/596/014  | Lamivudine Teva Pharma B.V. | 300 mg     | Film-coated tablet    | Oral use                  | Bottle (HDPE)                         | 30 tablets  |
| EU/1/09/596/015  | Lamivudine Teva Pharma B.V. | 150 mg     | Film-coated tablet    | Oral use                  | Blister (PVC/PVdC/alu)                | 80 tablets  |
| EU/1/09/596/016  | Lamivudine Teva Pharma B.V. | 300 mg     | Film-coated tablet    | Oral use                  | Blister (PVC/PVdC/alu)                | 80 tablets  |
| EU/1/09/596/017  | Lamivudine Teva Pharma B.V. | 150 mg     | Film-coated tablet    | Oral use                  | Bottle (HDPE) with tamper-evident cap | 60 tablets  |
| EU/1/09/596/018  | Lamivudine Teva Pharma B.V. | 300 mg     | Film-coated tablet    | Oral use                  | Bottle (HDPE) with tamper-evident cap | 30 tablets  |